Oracle Corporation is rated a Hold due to the balance in opportunities and risks, operationally and financially. Read more on ...
Oracle expands its AI database security strategy with new data protection, patching, and cyber resilience tools to help ...
Oracle (ORCL 1.72%) has become one of the biggest battleground stocks when it comes to artificial intelligence (AI), and investors were in a selling mood after the software-as-a-s ...
Oracle (ORCL) shares fell sharply this week over concerns about the company's AI spending plans. Should investors buy the dip? Seeking Alpha analysts weigh in.
Oracle warned its corporate customers that there is a critical-rated vulnerability in its PeopleSoft software, which is used by large companies to manage payroll and human resources, a day after a ...
Oracle topped quarterly expectations, but free cash flow is negative, and the company plans to raise more capital for data center projects.
A Kennedy, a former Republican, and a political insider: Meet the crowded field of Democrats running in NY-12 ...
CNN projects Graham Platner will win the Democratic Senate primary in Maine. Ex-Trump advisor Caroline Sunshine says voters chose him because he ran on some of Trump’s key economic issues and looked ...
Send a note to Lindsey Crossmier, Jim McNett and our other editors. We read every email. By submitting this form, you agree to allow us to collect, store, and potentially publish your provided ...
WSJ Buy Side is The Wall Street Journal’s research and commerce team. Our commerce content is distinct from our newsroom coverage. We earn a commission from some links in our articles. Learn more.
While creatine use increased, there were modest declines in steroid use. HealthDay News — U.S. teens report less anabolic steroid use than they did two decades ago, but more recently, there has been a ...
Metformin use was associated with a 23% lower risk for all-cause mortality among US adults with arthritis. Metformin use is associated with a lower risk for all-cause mortality among adults in the ...